LONDON--(BUSINESS WIRE)--Oct 29, 2025--
TurinTech, the AI company behind Artemis, the AI engineering platform, today announced that Dr Greg Lavender, former Chief Technology Officer and Executive Vice President of Intel, has joined the company as Strategic Advisor, effective immediately.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251028930945/en/
Lavender brings over four decades of experience across AI infrastructure, cloud‑scale systems, and enterprise software. In his new role, he will support TurinTech’s executive team in shaping its technical strategy, accelerating enterprise adoption, and guiding the next phase of Artemis’s expansion—from advanced code optimization to intelligent, scalable agentic orchestration.
“Having led large engineering teams, I’ve seen firsthand how AI and agent-based systems are transforming how software is built - working alongside human developers, instead of replacing them. This shift brings real risks and challenges, but also tremendous potential to elevate the quality and impact of engineering work,” said Dr Greg Lavender, Strategic Advisor to TurinTech. “What impressed me about TurinTech is their focus on engineering discipline and outcome-driven design. They’re not just building AI tools—they’re creating the systems needed to make this transformation work at scale. I’m excited to support the team as they deliver this next generation of agentic platforms for modern engineering.”
Lavender served as Chief Technology Officer and Executive Vice President at Intel from June 2021 through June 2025, having joined from VMware, where he was CTO. At Intel, he led the Software and Advanced Technology Group, including Intel Labs, Product Security & Assurance, IT/InfoSec, and leading market initiatives in AI software, confidential computing, and system-level innovation across the Intel product portfolio. Prior to Intel, he held senior engineering and leadership roles at VMware, Citi, Cisco, and Sun Microsystems, and began his career in academia, spending 14 years on the computer science faculty at the University of Texas at Austin.
“Greg has helped shape the software and hardware infrastructure that powers today’s AI systems,” said Dr Leslie Kanthan, CEO of TurinTech. “He understands what it takes to bring intelligence to enterprise development. Having collaborated with us during his time at Intel, he’s already seen firsthand the transformative potential of Artemis.”
Intel is among several enterprise customers leveraging Artemis to optimize code performance, reduce AI‑related risk, and accelerate software modernization. Lavender’s familiarity with Artemis’s architecture and outcomes makes him uniquely positioned to advise as TurinTech scales to meet growing enterprise demand for governed, AI‑driven engineering systems.
Artemis helps organizations evolve and validate the code they already have—whether written by humans or generated by AI. Through agentic planning, safe orchestration, and integrated validation, Artemis transforms ideas, prototypes, or unstructured code into optimized, production‑ready outcomes.
Lavender’s appointment comes as TurinTech accelerates global adoption across financial services, infrastructure, and software verticals.
About TurinTech
TurinTech is the company behind Artemis, the AI engineering platform built to help organizations turn code into measurable business outcomes. Artemis analyzes, plans, and optimizes code across the entire development lifecycle—improving performance, reducing cost, and ensuring every result is validated and production-ready.
To learn more, visit www.turintech.ai
Sign up to join the waitlist for early access to TurinTech’s latest agentic engineering technologies:turintech.ai/waitlist
TurinTech Appoints Former Intel CTO Greg Lavender as Strategic Advisor
SAN FRANCISCO & JACKSONVILLE, Fla.--(BUSINESS WIRE)--Jan 12, 2026--
Abridge, the leading enterprise-grade AI for clinical conversations, is collaborating with Availity, the nation’s largest real-time health information network, to launch a first-of-its kind prior authorization experience. The engagement uses cutting-edge technology grounded in the clinician-patient conversation to facilitate a more efficient process between clinicians and health plans in medical necessity review.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112960386/en/
Rather than creating parallel AI systems across healthcare stakeholders, Abridge and Availity are working together to ensure shared clinical context at the point of conversation powers administrative processes, such as prior authorization review and submission, improving outcomes for patients and the teams delivering care.
This collaboration unites two trusted and scaled organizations: combining Abridge’s enterprise-grade AI platform, serving over 200 health systems and projected to support over 80 million patient-clinician conversations in 2026, with Availity’s next-generation, FHIR-native Intelligent Utilization Management solution, which helps payers and providers digitize and operationalize coverage requirements within administrative workflows.
Availity’s FHIR-native APIs enable fast, scalable, and secure connectivity of payer information across the entire healthcare ecosystem. With Abridge’s Contextual Reasoning Engine technology, clinicians can gain visibility into relevant clinical information during the conversation to support documentation aligned with prior authorization requirements.
“At Availity, we’ve invested in building AI-powered, FHIR-native APIs designed to bring clinical policy logic directly into provider workflows,” said Russ Thomas, CEO of Availity. “By embedding our technology at the point of conversation, we’re enabling faster, more transparent utilization management decisions rooted in clinical context. We’re excited to collaborate with Abridge and to demonstrate what’s possible when payer intelligence meets real-time provider workflows.”
The development of real-time prior authorization is just a component of a broader revenue cycle collaboration that is focused on applying real-time conversational intelligence across the patient, provider, and payer experiences. The companies intend to support integration by collaborating on workflow alignment between their respective platforms in the following areas:
“Abridge and Availity are each bringing national scale, deep trust, and a track record of solving important challenges across the care and claims experience to this partnership,” said Dr. Shiv Rao, CEO and Co-Founder of Abridge. “We’re building real-time bridges between patients, providers, and payers, unlocking shared understanding, focused at the point of conversation.”
About Availity
Availity empowers payers and providers to deliver transformative patient experiences by enabling the seamless exchange of clinical, administrative, and financial information. As the nation's largest real-time health information network, Availity develops intelligent, automated, and interoperable solutions that foster collaboration and shared value across the healthcare ecosystem. With connections to over 95% of payers, more than 3 million providers, and over 2,000 trading partners, Availity provides mission-critical connectivity to drive the future of healthcare innovation. For more information, including an online demonstration, please visit www.availity.com or call 1.800.AVAILITY (282.4548). Follow us on LinkedIn.
About Abridge
Abridge was founded in 2018 to power deeper understanding in healthcare. Abridge is now trusted by more than 200 of the largest and most complex health systems in the U.S. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.
Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge is the only solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge is setting the industry standard for the responsible deployment of AI across health systems.
Abridge was awarded Best in KLAS 2025 for Ambient AI in addition to other accolades, including Forbes 2025 AI 50 List, TIME Best Inventions of 2024, and Fortune’s 2024 AI 50 Innovators.
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
Abridge and Availity Collaborate to Redefine Payer-Provider Synergy at the Point of Conversation
